Vir Biotechnology, Inc. (VIR)
8.39
-0.48
(-5.41%)
USD |
NASDAQ |
Nov 20, 16:00
8.38
-0.01
(-0.12%)
After-Hours: 20:00
Vir Biotechnology Net Income (Quarterly) : -96.25M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -96.25M |
| June 30, 2026 | 80.08M |
| March 31, 2026 | -125.70M |
| December 31, 2025 | -42.92M |
| September 30, 2025 | -163.14M |
| June 30, 2025 | -110.96M |
| March 31, 2025 | -120.96M |
| December 31, 2024 | -104.59M |
| September 30, 2024 | -213.72M |
| June 30, 2024 | -138.38M |
| March 31, 2024 | -65.28M |
| December 31, 2023 | -115.97M |
| September 30, 2023 | -163.41M |
| June 30, 2023 | -194.78M |
| March 31, 2023 | -140.96M |
| December 31, 2022 | -101.60M |
| September 30, 2022 | 175.31M |
| Date | Value |
|---|---|
| June 30, 2022 | -76.49M |
| March 31, 2022 | 518.62M |
| December 31, 2021 | 525.25M |
| September 30, 2021 | 110.43M |
| June 30, 2021 | 61.81M |
| March 31, 2021 | -168.91M |
| December 31, 2020 | -105.65M |
| September 30, 2020 | -84.61M |
| June 30, 2020 | -31.17M |
| March 31, 2020 | -77.24M |
| December 31, 2019 | -63.77M |
| September 30, 2019 | -48.31M |
| June 30, 2019 | -33.93M |
| March 31, 2019 | -28.67M |
| December 31, 2018 | -26.39M |
| September 30, 2018 | -33.46M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Moderna, Inc. | 162.00M |
| Vaxcyte, Inc. | -297.06M |
| Oncolytics Biotech, Inc. | -9.705M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -28.46M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | -0.188M |
| Total Expenses (Quarterly) | 96.06M |
| EPS Diluted (Quarterly) | -0.5686 |
| Enterprise Value | 1.052B |
| Earnings Yield | -14.97% |
| Normalized Earnings Yield | -14.76 |